Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Clinical trial NCT04750473 · COMPLETED

Trial details

NCT number: NCT04750473
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Invasive Breast Lobular Carcinoma Metastatic Breast Lobular Carcinoma Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2021-07-16
Primary completion: 2023-03-21
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.